Page last updated: 2024-09-03

caprylates and ER-Negative PR-Negative HER2-Negative Breast Cancer

caprylates has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fujii, K; Hirao-Suzuki, M; Kamishikiryo, J; Kobayashi, T; Koga, T; Sakai, G; Sugihara, N; Takeda, S; Takiguchi, M; Tanaka, M; Toda, A1

Other Studies

1 other study(ies) available for caprylates and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Perfluorooctanoic acid (PFOA) as a stimulator of estrogen receptor-negative breast cancer MDA-MB-231 cell aggressiveness: Evidence for involvement of fatty acid 2-hydroxylase (FA2H) in the stimulated cell migration.
    The Journal of toxicological sciences, 2022, Volume: 47, Issue:4

    Topics: Caprylates; Cell Movement; Fluorocarbons; Humans; Mixed Function Oxygenases; Receptors, Estrogen; Triple Negative Breast Neoplasms

2022